Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Menggongzi Tibetan Tea Special Drink in Hyperlipidemia
NCT06551298Not yet recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Oct 2024
- Primary completion
- Aug 2025
- Countries
- 1
01
Overview
Randomised, open-label trial (3 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoints: Total Cholesterol at 4 weeks and Triglycerides at 4 weeks. Planned start Oct 2024; status: not yet recruiting.
Beyond the preview
Go deeper on NCT06551298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06551298.